Wolfe Research Downgrades 10x Genomics to Peer Perform
Portfolio Pulse from Benzinga Newsdesk
Wolfe Research has downgraded 10x Genomics (NASDAQ:TXG) from Outperform to Peer Perform, as per analyst Doug Schenkel.
June 27, 2024 | 9:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wolfe Research analyst Doug Schenkel has downgraded 10x Genomics from Outperform to Peer Perform, indicating a less favorable outlook for the company's stock performance.
The downgrade from Outperform to Peer Perform by a reputable analyst suggests a less optimistic view on the stock's future performance. This could lead to a negative short-term impact on the stock price as investors may adjust their positions based on the new rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100